Study to Determine the Hepatitis C Virus Infection Prevalence Among Patients Attended Primarily for Vasculitis

Key facts

Sponsor

Hospital General de Mexico

Principal Investigator

FATIMA HIGUERA-DE LA TIJERA, MSc.

Hospital General de México

Enrollment

1000 target

Eligibility

All sexes

Timeline

2018 – 2022

Study locations (1)

• Hospital General de Mexico, Mexico City, Mexico

Collaborators

AbbVie

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Vasculitis

Additional recruiting or active studies for the same condition.

• RECRUITINGNCT07278609
  The RheumSafer Study: Improving Medication Appropriateness in People With Rheumatic Conditions
  McGill University Health Centre/Research Institute of the McGill University Health Centre
• ENROLLING BY INVITATIONPHASE4NCT06763783
  Vaccination Against Herpes Zoster in Patients With Inflammatory Rheumatic Diseases
  Region Skane
• RECRUITINGNCT06779799
  Characterization of "Bamboo" and Other Vocal Cord Lesions Responsible for Dysphonia in Patients With Systemic Autoimmune Diseases (BAMBOO)
  University Hospital, Brest
• RECRUITINGNCT06698614
  MEMRI and Kidney Disease
  University of Edinburgh
• RECRUITINGNCT06593041
  ROLE of PLATELETS in the PATHOPHYSIOLOGY of SYSTEMIC LUPUS
  University Hospital, Strasbourg, France
• RECRUITINGNCT06824714
  Prediction of Risk of Vascular Structural Damage in Patients With Large Vessel Vasculitis (LVV) Based on PET/MRA Image Evaluation System
  Nanjing Medical University
• RECRUITINGNCT05734404
  Longitudinal Study for Central Nervous System Vasculitis
  University of Pennsylvania
• RECRUITINGNANCT05937880
  Leflunomide for Henoch-Schonlein Purpura
  Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

See all trials for Vasculitis →